Evidence map›Paper›PMID 42192301›Full record

ReviewThe journal of headache and pain2026

From bench to bedside: relevant animal models across the migraine attack phases.

Georgii Krivoshein, Mignon van der Watt, Teresa Jordà-Baleri, Katrin Põld, Viktor Gkotzamanis, Arn M J M van den Maagdenberg, Eloisa Rubio-Beltran, Philip R Holland, School of Advanced Studies of the European Headache Federation (EHF-SAS)

Abstract readReview
In one paragraph

Review in The journal of headache and pain, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Georgii Krivoshein *Department of Human Genetics, Leiden University Medical Center, Leiden, The Netherlands.
Mignon van der Watt *Headache Group, Wolfson Sensory, Pain and Regeneration Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.
Teresa Jordà-BaleriDepartment of Medicine, Neurology Department, Headache Clinic, Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain.
Katrin PõldDepartment of Pharmacology, University of Tartu, Tartu, Estonia.
Viktor GkotzamanisFirst Department of Neurology, School of Medicine, National and Kapodistrian University of Athens, Aeginition University Hospital, Athens, Greece.
Arn M J M van den MaagdenbergDepartment of Human Genetics, Leiden University Medical Center, Leiden, The Netherlands.
Eloisa Rubio-BeltranHeadache Group, Wolfson Sensory, Pain and Regeneration Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.
Philip R HollandHeadache Group, Wolfson Sensory, Pain and Regeneration Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK. Philip.holland@kcl.ac.uk.
School of Advanced Studies of the European Headache Federation (EHF-SAS)

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Migraine is a debilitating brain disorder for which there remains a considerable therapeutic gap that needs to be addressed in order to develop novel effective treatment options for patients. Preclinical translational models have contributed significantly to migraine research by improving our understanding of migraine pathophysiology as well as identifying and validating new drug targets. In this review, we will summarise key animal models and discuss how commonly used experimental readouts used in these models can be integrated for the investigation of the various phases of a migraine attack. A major focus is to highlight the translational potential of the experimental models and how they can help bridge the gap between preclinical research and clinical application and how increased understanding of fundamental disease mechanisms can form the basis of improved migraine treatments. Providing such a resource may inform the broader migraine research community on which model and readout they might consider when studying a specific phase of the migraine attack, when evaluating the efficacy of new possible drugs and innovative therapeutic strategies.

Indexed as

Disease Models, AnimalMigraine DisordersTranslational Research, BiomedicalAnimalsHumans

Identifiers

PMID42192301
PMCPMC13202895

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.